全文获取类型
收费全文 | 162篇 |
免费 | 3篇 |
国内免费 | 1篇 |
专业分类
妇产科学 | 6篇 |
基础医学 | 20篇 |
临床医学 | 22篇 |
内科学 | 26篇 |
皮肤病学 | 3篇 |
神经病学 | 3篇 |
特种医学 | 2篇 |
外科学 | 16篇 |
综合类 | 4篇 |
预防医学 | 3篇 |
眼科学 | 1篇 |
药学 | 34篇 |
肿瘤学 | 26篇 |
出版年
2022年 | 1篇 |
2021年 | 8篇 |
2020年 | 4篇 |
2019年 | 3篇 |
2018年 | 12篇 |
2017年 | 2篇 |
2016年 | 1篇 |
2015年 | 6篇 |
2014年 | 10篇 |
2013年 | 7篇 |
2012年 | 20篇 |
2011年 | 15篇 |
2010年 | 10篇 |
2009年 | 4篇 |
2008年 | 13篇 |
2007年 | 11篇 |
2006年 | 13篇 |
2005年 | 13篇 |
2004年 | 11篇 |
2003年 | 1篇 |
2002年 | 1篇 |
排序方式: 共有166条查询结果,搜索用时 31 毫秒
81.
82.
Isolated hand weakness due to stroke is infrequently observed, and often misdiagnosed as peripheral lesions. This study investigated the clinical and radiologic profiles in such patients. Five men and one woman were studied. All patients underwent cranial magnetic resonance imaging (MRI) to confirm the diagnosis. Four patients had uniform weakness and the other two had either differential radial or ulnar weakness, respectively. MRI showed acute infarctions involving the hand knob area of the primary motor cortex (M1) in five patients and the postcentral gyrus sparing the precentral gyrus in one patient. Two patients with uniform digit weakness had additional involvement of the inferior parietal lobule. These findings suggest that isolated or predominant hand weakness in patients with cerebral infarctions is not necessarily caused by lesions in the M1 knob area, and that the control center of hand movement is not limited to the knob area alone. 相似文献
83.
84.
Tsung-Hui Hu Ming-Chao Tsai Yen-Ta Chen Yu-Shu Chien Chao-Hung Hung Te-Chuan Chen Po-Lin Tseng Kuo-Chin Chang Yi-Hao Yen 《Hepatology International》2012,6(2):449-456
Background
Early prediction of lamivudine (LAM) response by individualized monitoring of serum HBV DNA like roadmap concept, and investigation of the outcome after LAM discontinuation in renal transplant recipients (RTRs) with chronic hepatitis B (CHB). 相似文献85.
86.
87.
88.
Yu-Ting Yuan Ying-Hwa Chen Po-Lin Chen Han-Chin Tsai I-Ming Chen Zen-Chung Weng Chun-Che Shih Hsiao-Huang Chang 《Journal of the Chinese Medical Association》2013,76(12):698-702
BackgroundAortic valve replacement (AVR) remains the gold standard treatment for symptomatic severe aortic stenosis (AS). For the past 10 years, transcatheter aortic valve implantation (TAVI) has been applied in patients with high surgical mortality and morbidity risks. The preliminary results of our TAVI patients are presented in this study.MethodsTen high-risk patients with severe AS, for AVR, were referred and accepted for TAVI in the 6 month period from May 2010 to October 2010. The patient age, logistic EuroSCORE, femoral arterial diameter, aorta annulus size, aorta valve area (AVA), mean aortic pressure gradient (MPG), as well as coronary angiography results were all collected. Six patients were treated via the transapical approach in March 2010, whereas the other four were treated with the transfemoral approach, according to their femoral artery diameter and arterial quality. This study focuses on the immediate, 1 month, 3 month, and 1 year results of TAVI.ResultsThe average age of the 10 patients receiving TAVI was 81.5 years. The mean calculated EuroSCORE was 28.3 ± 7.9%. The mean AVA was 0.61 ± 0.19 cm2. The MPG was 48 ± 16 mmHg. The surgical technical success achieved 100%. There was no reported moderate to severe postoperative paravalvular aortic regurgitation, permanent complete atrioventricular block, major access site complication, or embolic stroke. Chronic renal failure, which necessitated permanent hemodialysis, developed in 10% of the patients. One acute myocardial infarction and one case of pneumonia developed postoperatively. The AVA was increased by 251%, whereas the MPG was decreased by 80% at the 3 month follow-up. The 30-day mortality rate was 10%. The all-cause 1-year mortality rate was 20%.ConclusionThis new technique and device requires greater caution and needs more practice to accumulate sufficient experience. The studied patients were very fragile, due to old age and multiple comorbidities. Our results are similar to findings of multicenter trials. With careful patient screening and selection, TAVI can be a promising treatment for high-risk severe AS patients. 相似文献
89.
Zhong-Zhe Lin Yung-Ming Jeng Fu-Chang Hu Hung-Wei Pan Hsin-Wei Tsao Po-Lin Lai Po-Huang Lee Ann-Lii Cheng 《BMC cancer》2010,10(1):461
Background
To investigate the significance of Aurora B expression in hepatocellular carcinoma (HCC). 相似文献90.
Tang JY Xiao TZ Oda Y Chang KS Shpall E Wu A So PL Hebert J Bikle D Epstein EH 《Cancer prevention research (Philadelphia, Pa.)》2011,4(5):744-751
Constitutive Hedgehog (HH) signaling underlies several human tumors, including basal cell carcinoma (BCC). Recently, Bijlsma and colleagues reported a new biologic function for vitamin D3 in suppressing HH signaling in an in vitro model system. On the basis of that work, we have assessed effects of vitamin D3 on HH signaling and proliferation of murine BCCs in vitro and in vivo. We find that indeed in BCC cells, vitamin D3 blocks both proliferation and HH signaling as assessed by mRNA expression of the HH target gene Gli1. These effects of vitamin D3 on Gli1 expression and on BCC cell proliferation are comparable to the effects of cyclopamine, a known inhibitor of the HH pathway. These results are specific for vitamin D3, because the precursor 7-dehydrocholesterol and the downstream products 25-hydroxy vitamin D3 [25(OH)D] and 1,25-dihydroxy vitamin D3 [1,25(OH)(2)D] are considerably less effective in reducing either Gli1 mRNA or cellular proliferation. Moreover, these effects seem to be independent of the vitamin D receptor (VDR) because short hairpin RNA knockdown of VDR does not abrogate the anti-HH effects of D3 despite reducing expression of the VDR target gene 24-hydroxylase. Finally, topical vitamin D3 treatment of existing murine BCC tumors significantly decreases Gli1 and Ki67 staining. Thus, topical vitamin D3 acting via its HH inhibiting effect may hold promise as an effective anti-BCC agent. 相似文献